HealthDay - WEDNESDAY, Aug. 31 (HealthDay News) -- Some breast cancer patients over the age of 60 who have small, early-stage tumors can skip hormone therapy without increasing their risk of death, a new study says.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.